|^~\&RNZTMCRNZTMCOPTEMISTMC20260505120023OMGO19MOSA4BQ7:7D1DP2.4RNZ0446628RNZ02MR90295044CRISPI450 583 9028NHSNHPAYNEVALERIEHILDAMRS19590724F5 MOORLANDS ROADVERWOODDORSETBH31 7PD012029506130""NJ81058G9002348BNWTQI7323588-0196389834CRISCM2026050212596202605051200RNZNDCC4594336MOE MaungRNZ02OPD202604160000800LT16445RNZNDCRNZ02TQI7323588-0196389834CRISCCHAPCCT Thorax abdomen pelvis with contrast95419258RNZ96389834C2026050212596TMCRNZTMC Allocation (RNZ02)RA71877Raviraj Ghatkamble (Specialist Radiog)202605021259202605021313XCTRNZ02CT MR1TXSTUDYUID1.2.826.0.1.2112370.46.1.963898342CESND_REASON_CDSend reason codeCRIS3SRREPSent: ReportingCRIS3202605051200RNZNDCNicola Compton - (RNZ02)3TXREASONReason for examinationCRIS3Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response.202605051200RNZNDCNicola Compton - (RNZ02)4TXREASONReason for examinationCRIS3~(Information via Order Comms)202605051200RNZNDCNicola Compton - (RNZ02)5TXHISTORYClinical historyCRIS3eGFR202605051200RNZNDCNicola Compton - (RNZ02)6TXHISTORYClinical historyCRIS3Last Test: 16 April 2026 15:00 (Sample Received)202605051200RNZNDCNicola Compton - (RNZ02)7TXHISTORYClinical historyCRIS3Result: 76 mL/min/1.73m*2202605051200RNZNDCNicola Compton - (RNZ02)8TXHISTORYClinical historyCRIS3Review ReportID - 27632715202605051200RNZNDCNicola Compton - (RNZ02)9TXHISTORYClinical historyCRIS3Clinical Details:202605051200RNZNDCNicola Compton - (RNZ02)10TXHISTORYClinical historyCRIS3Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response. Please scan at the end of this April/ early May202605051200RNZNDCNicola Compton - (RNZ02)11TXHISTORYClinical historyCRIS3~(Information via Order Comms)202605051200RNZNDCNicola Compton - (RNZ02)12TXCOMMENTEvent commentCRIS3Required on 16 April 2026 at 1655202605051200RNZNDCNicola Compton - (RNZ02)13TXCOMMENTEvent commentCRIS3SITE: RNZ02202605051200RNZNDCNicola Compton - (RNZ02)14TXCOMMENTEvent commentCRIS3Urgency Details: Please arrange MRI brain and CT CAP on the same day with a close time202605051200RNZNDCNicola Compton - (RNZ02)15TXCOMMENTEvent commentCRIS3Infection risk?: N202605051200RNZNDCNicola Compton - (RNZ02)16TXCOMMENTEvent commentCRIS3CONTACT NAME:: Cho May Than202605051200RNZNDCNicola Compton - (RNZ02)17TXCOMMENTEvent commentCRIS3CONTACT NUMBER: 1488202605051200RNZNDCNicola Compton - (RNZ02)18TXCOMMENTEvent commentCRIS3QUESTIONS: Allergy to contrast media?202605051200RNZNDCNicola Compton - (RNZ02)19TXCOMMENTEvent commentCRIS3QUESTIONS: Answer:N202605051200RNZNDCNicola Compton - (RNZ02)20TXCOMMENTEvent commentCRIS3QUESTIONS: Diabetic Patient?202605051200RNZNDCNicola Compton - (RNZ02)21TXCOMMENTEvent commentCRIS3QUESTIONS: Answer:N202605051200RNZNDCNicola Compton - (RNZ02)22TXCOMMENTEvent commentCRIS3QUESTIONS: Risk factors for renal impairment?202605051200RNZNDCNicola Compton - (RNZ02)23TXCOMMENTEvent commentCRIS3QUESTIONS: Answer:None202605051200RNZNDCNicola Compton - (RNZ02)24TXCOMMENTEvent commentCRIS3QUESTIONS: Is the patient ACE inhibitor or angiotensin receptor blocker?202605051200RNZNDCNicola Compton - (RNZ02)25TXCOMMENTEvent commentCRIS3QUESTIONS: Answer:N202605051200RNZNDCNicola Compton - (RNZ02)26TXCOMMENTEvent commentCRIS3REASON: Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response.202605051200RNZNDCNicola Compton - (RNZ02)27TXCOMMENTEvent commentCRIS3PROTOCOL-QUESTION: Is the patient currently an IN : No202605051200RNZNDCNicola Compton - (RNZ02)28TXCOMMENTEvent commentCRIS3~(Information via Order Comms)202605051200RNZNDCNicola Compton - (RNZ02)29TXSAFETYQClinical safety questionsCRIS3Allergy to contrast media?202605051200RNZNDCNicola Compton - (RNZ02)30TXSAFETYQClinical safety questionsCRIS3Answer:N202605051200RNZNDCNicola Compton - (RNZ02)31TXSAFETYQClinical safety questionsCRIS3Diabetic Patient?202605051200RNZNDCNicola Compton - (RNZ02)32TXSAFETYQClinical safety questionsCRIS3Answer:N202605051200RNZNDCNicola Compton - (RNZ02)33TXSAFETYQClinical safety questionsCRIS3Risk factors for renal impairment?202605051200RNZNDCNicola Compton - (RNZ02)34TXSAFETYQClinical safety questionsCRIS3Answer:None202605051200RNZNDCNicola Compton - (RNZ02)35TXSAFETYQClinical safety questionsCRIS3Is the patient ACE inhibitor or angiotensin receptor blocker?202605051200RNZNDCNicola Compton - (RNZ02)36TXSAFETYQClinical safety questionsCRIS3Answer:N202605051200RNZNDCNicola Compton - (RNZ02)37TXSAFETYQClinical safety questionsCRIS3~(Information via Order Comms)202605051200RNZNDCNicola Compton - (RNZ02)38TXEVENT_SUMMARYEvent summaryCRIS3~(Event summary)202605051200RNZNDCNicola Compton - (RNZ02)39TXEVENT_SUMMARYEvent summaryCRIS3Event E-95419258: Salisbury District Hospital, 02/05/26 1259
202605051200RNZNDCNicola Compton - (RNZ02)40TXEVENT_SUMMARYEvent summaryCRIS3Referral Source: Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
202605051200RNZNDCNicola Compton - (RNZ02)41TXEVENT_SUMMARYEvent summaryCRIS3Referrer: MOE Maung, SDH Outpatients
202605051200RNZNDCNicola Compton - (RNZ02)42TXEVENT_SUMMARYEvent summaryCRIS3Request Date: 16/04/26
202605051200RNZNDCNicola Compton - (RNZ02)43TXEVENT_SUMMARYEvent summaryCRIS3Appointment Date: Saturday, 02 May, 2026
202605051200RNZNDCNicola Compton - (RNZ02)44TXEVENT_SUMMARYEvent summaryCRIS3Request Category: NHS PATIENT Patient Type: OUT PATIENT
202605051200RNZNDCNicola Compton - (RNZ02)45TXEVENT_SUMMARYEvent summaryCRIS3Mobility: Walking
202605051200RNZNDCNicola Compton - (RNZ02)46TXEVENT_SUMMARYEvent summaryCRIS3Practitioner: Dr Jonathan Arnott (RNZ02) (C7046956)
202605051200RNZNDCNicola Compton - (RNZ02)47TXEVENT_SUMMARYEvent summaryCRIS3Intended Radiologist: TMC Allocation (RNZ02) (TMCRNZ)
202605051200RNZNDCNicola Compton - (RNZ02)48TXEVENT_SUMMARYEvent summaryCRIS3Clinical History: eGFR202605051200RNZNDCNicola Compton - (RNZ02)49TXEVENT_SUMMARYEvent summaryCRIS3Last Test: 16 April 2026 15:00 (Sample Received)202605051200RNZNDCNicola Compton - (RNZ02)50TXEVENT_SUMMARYEvent summaryCRIS3Result: 76 mL/min/1.73m*2202605051200RNZNDCNicola Compton - (RNZ02)51TXEVENT_SUMMARYEvent summaryCRIS3Review ReportID - 27632715202605051200RNZNDCNicola Compton - (RNZ02)52TXEVENT_SUMMARYEvent summaryCRIS3Clinical Details:202605051200RNZNDCNicola Compton - (RNZ02)53TXEVENT_SUMMARYEvent summaryCRIS3Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response. Please scan at the end of this April/ early May202605051200RNZNDCNicola Compton - (RNZ02)54TXEVENT_SUMMARYEvent summaryCRIS3(Information via Order Comms)
202605051200RNZNDCNicola Compton - (RNZ02)55TXEVENT_SUMMARYEvent summaryCRIS3202605051200RNZNDCNicola Compton - (RNZ02)56TXEVENT_SUMMARYEvent summaryCRIS3Status History:
202605051200RNZNDCNicola Compton - (RNZ02)57TXEVENT_SUMMARYEvent summaryCRIS3Date Code Status Start End User
202605051200RNZNDCNicola Compton - (RNZ02)58TXEVENT_SUMMARYEvent summaryCRIS305/05/26 STP Send to: Pending Nicola Compton - (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)59TXEVENT_SUMMARYEvent summaryCRIS3Comment: Sent to Destination TMC (TMC) using method INTRNZTMCLIVEFROMCRIS by user RNZNDC with note:
202605051200RNZNDCNicola Compton - (RNZ02)60TXEVENT_SUMMARYEvent summaryCRIS302/05/26 ATP Attend Amanda Middleton (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)61TXEVENT_SUMMARYEvent summaryCRIS320/04/26 PRTLTRLetter Printed Stacey Salmon (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)62TXEVENT_SUMMARYEvent summaryCRIS3Comment: Letter for this event has been printed
202605051200RNZNDCNicola Compton - (RNZ02)63TXEVENT_SUMMARYEvent summaryCRIS320/04/26 APD Diary 02/05/26 Stacey Salmon (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)64TXEVENT_SUMMARYEvent summaryCRIS3Comment: Moving as advised on MRI request for scans to be booked on same day - Rebook SS 20.04202605051200RNZNDCNicola Compton - (RNZ02)65TXEVENT_SUMMARYEvent summaryCRIS3202605051200RNZNDCNicola Compton - (RNZ02)66TXEVENT_SUMMARYEvent summaryCRIS320/04/26 RR Requested/Received 16/04/26 Stacey Salmon (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)67TXEVENT_SUMMARYEvent summaryCRIS3Comment: Moving as advised on MRI request for scans to be booked on same day - Rebook SS 20.04
202605051200RNZNDCNicola Compton - (RNZ02)68TXEVENT_SUMMARYEvent summaryCRIS320/04/26 CH Hosp Cancel 02/05/26 Stacey Salmon (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)69TXEVENT_SUMMARYEvent summaryCRIS3Comment: Moving as advised on MRI request for scans to be booked on same day - Rebook SS 20.04
202605051200RNZNDCNicola Compton - (RNZ02)70TXEVENT_SUMMARYEvent summaryCRIS317/04/26 PRTLTRLetter Printed Stacey Salmon (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)71TXEVENT_SUMMARYEvent summaryCRIS3Comment: Letter for this event has been printed
202605051200RNZNDCNicola Compton - (RNZ02)72TXEVENT_SUMMARYEvent summaryCRIS317/04/26 APD Diary 02/05/26 Stacey Salmon (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)73TXEVENT_SUMMARYEvent summaryCRIS3Comment: Required Date : 16-Apr-2026, Required Time : 1655, Requested By : Maung Moe
202605051200RNZNDCNicola Compton - (RNZ02)74TXEVENT_SUMMARYEvent summaryCRIS316/04/26 VC Completed Dr Jonathan Arnott (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)75TXEVENT_SUMMARYEvent summaryCRIS3Comment: Protocol: CT Chest/Abdo/Pelvis - With IV contrast202605051200RNZNDCNicola Compton - (RNZ02)76TXEVENT_SUMMARYEvent summaryCRIS3202605051200RNZNDCNicola Compton - (RNZ02)77TXEVENT_SUMMARYEvent summaryCRIS31. Arterial phase Chest 202605051200RNZNDCNicola Compton - (RNZ02)78TXEVENT_SUMMARYEvent summaryCRIS32. Port venous Abdomen and Pelvis to include the lesser trochanters.202605051200RNZNDCNicola Compton - (RNZ02)79TXEVENT_SUMMARYEvent summaryCRIS3Smart prep at the aortic arch 202605051200RNZNDCNicola Compton - (RNZ02)80TXEVENT_SUMMARYEvent summaryCRIS370ml contrast at 3-4ml/s202605051200RNZNDCNicola Compton - (RNZ02)81TXEVENT_SUMMARYEvent summaryCRIS3202605051200RNZNDCNicola Compton - (RNZ02)82TXEVENT_SUMMARYEvent summaryCRIS3*****WEIGHT BASED CONTRAST DOSE*****202605051200RNZNDCNicola Compton - (RNZ02)83TXEVENT_SUMMARYEvent summaryCRIS3EXT202605051200RNZNDCNicola Compton - (RNZ02)84TXEVENT_SUMMARYEvent summaryCRIS3Contrast: OMNI350202605051200RNZNDCNicola Compton - (RNZ02)85TXEVENT_SUMMARYEvent summaryCRIS3Intended Clinician: OSOURCERNZ202605051200RNZNDCNicola Compton - (RNZ02)86TXEVENT_SUMMARYEvent summaryCRIS3Room: XCT202605051200RNZNDCNicola Compton - (RNZ02)87TXEVENT_SUMMARYEvent summaryCRIS3Booking Notes: eGFR202605051200RNZNDCNicola Compton - (RNZ02)88TXEVENT_SUMMARYEvent summaryCRIS3end of this April/ early May
202605051200RNZNDCNicola Compton - (RNZ02)89TXEVENT_SUMMARYEvent summaryCRIS316/04/26 RR Requested/Received Dr Jonathan Arnott (RNZ02)
202605051200RNZNDCNicola Compton - (RNZ02)90TXEVENT_SUMMARYEvent summaryCRIS3Comment: Required Date : 16-Apr-2026, Required Time : 1655, Requested By : Maung Moe
202605051200RNZNDCNicola Compton - (RNZ02)1eGFR2Last Test: 16 April 2026 15:00 (Sample Received)3Result: 76 mL/min/1.73m*24Review ReportID - 276327155Clinical Details:6Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response. Please scan at the end of this April/ early May7""
App:
RNZTMC
Facility:
RNZTMC
Msg Time:
May 5, 2026 12:00:23
Control ID:
MOSA4BQ7:7D1D
Type:
OMG_O19
Version:
HL7 v2.4
Account #
ID
RNZ0446628RNZ02MR90295044CRISPI450 583 9028NHSNH,
Sex
F
Name
PAYNE,
VALERIE HILDA MRS
DOB
July 24, 1959
Address
5 MOORLANDS ROAD VERWOOD CA BH31 7PD
Phone
01202950613
Location
Account Type
B
Order Date
May 5, 2026 12:00
Order ID
TQI7323588-01
Order Status
CM
Response Flag
Entered By
,
License #: RNZNDC
Entered At
RNZ02OPD
Ordered By
MOE Maung,
License #: C4594336
Report Name
CT Thorax abdomen pelvis with contrast
eGFR Last Test: 16 April 2026 15:00 (Sample Received) Result: 76 mL/min/1.73m*2 Review ReportID - 27632715 Clinical Details: Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response. Please scan at the end of this April/ early May
1.2.826.0.1.2112370.46.1.96389834
Send reason code
SRREP - Sent: Reporting
Reason for examination
Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response.
Reason for examination
~(Information via Order Comms)
Clinical history
eGFR
Clinical history
Last Test: 16 April 2026 15:00 (Sample Received)
Clinical history
Result: 76 mL/min/1.73m*2
Clinical history
Review ReportID - 27632715
Clinical history
Clinical Details:
Clinical history
Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response. Please scan at the end of this April/ early May
Clinical history
~(Information via Order Comms)
Event comment
Required on 16 April 2026 at 1655
Event comment
SITE: RNZ02
Event comment
Urgency Details: Please arrange MRI brain and CT CAP on the same day with a close time
Event comment
Infection risk?: N
Event comment
CONTACT NAME:: Cho May Than
Event comment
CONTACT NUMBER: 1488
Event comment
QUESTIONS: Allergy to contrast media?
Event comment
QUESTIONS: Answer:N
Event comment
QUESTIONS: Diabetic Patient?
Event comment
QUESTIONS: Answer:N
Event comment
QUESTIONS: Risk factors for renal impairment?
Event comment
QUESTIONS: Answer:None
Event comment
QUESTIONS: Is the patient ACE inhibitor or angiotensin receptor blocker?
Event comment
QUESTIONS: Answer:N
Event comment
REASON: Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response.
Event comment
PROTOCOL-QUESTION: Is the patient currently an IN : No
Event comment
~(Information via Order Comms)
Clinical safety questions
Allergy to contrast media?
Clinical safety questions
Answer:N
Clinical safety questions
Diabetic Patient?
Clinical safety questions
Answer:N
Clinical safety questions
Risk factors for renal impairment?
Clinical safety questions
Answer:None
Clinical safety questions
Is the patient ACE inhibitor or angiotensin receptor blocker?
Clinical safety questions
Answer:N
Clinical safety questions
~(Information via Order Comms)
Event summary
~(Event summary)
Event summary
Event E-95419258: Salisbury District Hospital, 02/05/26 1259
Met NSCLC, completed chemoimmunotherapy, currently on Second line chemotherapy with carboplatin and gemcitabine, completed 3 cycles so far. To assess the treatment response. Please scan at the end of this April/ early May
Event summary
(Information via Order Comms)
Event summary
Event summary
Status History:
Event summary
Date Code Status Start End User
Event summary
05/05/26 STP Send to: Pending Nicola Compton - (RNZ02)
Event summary
Comment: Sent to Destination TMC (TMC) using method INTRNZTMCLIVEFROMCRIS by user RNZNDC with note: